These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 24531083

  • 1. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
    Umegaki E, Kuramoto T, Kojima Y, Nouda S, Ishida K, Takeuchi T, Inoue T, Tokioka S, Higuchi K.
    Intern Med; 2014; 53(4):283-90. PubMed ID: 24531083
    [Abstract] [Full Text] [Related]

  • 2. Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study.
    Niwa Y, Nakamura M, Miyahara R, Ohmiya N, Watanabe O, Ando T, Kawashima H, Itoh A, Hirooka Y, Goto H.
    Digestion; 2009; 80(4):260-6. PubMed ID: 19844108
    [Abstract] [Full Text] [Related]

  • 3. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
    Kuramoto T, Umegaki E, Nouda S, Narabayashi K, Kojima Y, Yoda Y, Ishida K, Kawakami K, Abe Y, Takeuchi T, Inoue T, Murano M, Tokioka S, Higuchi K.
    BMC Gastroenterol; 2013 May 14; 13():85. PubMed ID: 23672202
    [Abstract] [Full Text] [Related]

  • 4. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
    Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C.
    Gastrointest Endosc; 2009 Jun 14; 69(7):1339-46. PubMed ID: 19243767
    [Abstract] [Full Text] [Related]

  • 5. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study.
    Xiong L, Huang X, Li L, Yang X, Liang L, Zhan Z, Ye Y, Chen M.
    Dig Liver Dis; 2015 Apr 14; 47(4):280-4. PubMed ID: 25660821
    [Abstract] [Full Text] [Related]

  • 6. Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70.
    Yanaka A, Zhang S, Sato D, Tauchi M, Suzuki H, Shibahara T, Matsui H, Nakahara A, Hyodo I.
    Digestion; 2007 Apr 14; 75(2-3):148-55. PubMed ID: 17684364
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
    Kobata Y, Yajima H, Yamao J, Tanaka Y, Fukui H, Takakura Y.
    Mod Rheumatol; 2009 Apr 14; 19(6):629-36. PubMed ID: 19728013
    [Abstract] [Full Text] [Related]

  • 8. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S, Takahashi Y, Gudis K, Seo T, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C.
    J Gastroenterol; 2011 Jan 14; 46(1):57-64. PubMed ID: 20924615
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, Hirooka Y, Goto H.
    J Gastroenterol; 2008 Jan 14; 43(4):270-6. PubMed ID: 18458842
    [Abstract] [Full Text] [Related]

  • 10. Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.
    Huang C, Lu B, Fan YH, Zhang L, Jiang N, Zhang S, Meng LN.
    World J Gastroenterol; 2014 Aug 21; 20(31):11012-8. PubMed ID: 25152605
    [Abstract] [Full Text] [Related]

  • 11. Teprenone improves gastric mucosal injury and dyspeptic symptoms in long-term nonsteroidal anti-inflammatory drug users.
    Gong Y, Huang X, Chen M, Xiong L.
    J Gastroenterol Hepatol; 2019 Aug 21; 34(8):1344-1350. PubMed ID: 30681185
    [Abstract] [Full Text] [Related]

  • 12. [Modern approach to the prevention and treatment of NSAID-gastropathy].
    Drozdov VN, Kim VA, Lazebnik LB.
    Eksp Klin Gastroenterol; 2011 Aug 21; (2):106-10. PubMed ID: 21560649
    [Abstract] [Full Text] [Related]

  • 13. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy.
    Caunedo-Alvarez A, Gómez-Rodríguez BJ, Romero-Vázquez J, Argüelles-Arias F, Romero-Castro R, García-Montes JM, Pellicer-Bautista FJ, Herrerías-Gutiérrez JM.
    Rev Esp Enferm Dig; 2010 Feb 21; 102(2):80-5. PubMed ID: 20361843
    [Abstract] [Full Text] [Related]

  • 14. Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
    Yajima H, Yamao J, Fukui H, Takakura Y.
    J Orthop Sci; 2007 Jul 21; 12(4):341-6. PubMed ID: 17657553
    [Abstract] [Full Text] [Related]

  • 15. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
    Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I.
    Gastroenterology; 2005 May 21; 128(5):1172-8. PubMed ID: 15887101
    [Abstract] [Full Text] [Related]

  • 16. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
    Wildgrube HJ, Kierschke G, Nowak H, Weigmann I, Terhaag B.
    Arzneimittelforschung; 2002 May 21; 52(4):264-72. PubMed ID: 12040969
    [Abstract] [Full Text] [Related]

  • 17. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.
    Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI.
    Gastroenterology; 1999 Feb 21; 116(2):254-8. PubMed ID: 9922304
    [Abstract] [Full Text] [Related]

  • 18. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    Satoh H, Amagase K, Takeuchi K.
    J Pharmacol Exp Ther; 2014 Feb 21; 348(2):227-35. PubMed ID: 24254524
    [Abstract] [Full Text] [Related]

  • 19. [Efficiency of famotidin in prophylaxis of NSAIDs-induced gastropathy: result of multicenter research ZASLON-1 (protection of gastric mucosa from non-steroidal anti-inflammatory drugs].
    Lazebnik LB, Drozdov VN, Kim VA.
    Eksp Klin Gastroenterol; 2009 Feb 21; (2):3-9. PubMed ID: 19552017
    [Abstract] [Full Text] [Related]

  • 20. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
    Fujimori S, Gudis K, Takahashi Y, Seo T, Yamada Y, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C.
    Eur J Clin Invest; 2010 Jun 21; 40(6):504-10. PubMed ID: 20412292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.